Reduced TFEB expression resulted in lysosomal deficits |
AD patient lymphocytes and monocytes |
|
[79] |
Selective nuclear TFEB exclusion |
AD patient brain samples |
Negative correlation between pathology & nuclear TFEB levels |
[129] |
TFEB is retained in cytosol hence lysosomal activity is reduced in AD patient fibroblasts & iPSC-derived human |
Double presenilin KO cells, AD patient fibroblasts & iPSC-derived human AD neurons |
|
[80] |
APOE ɛ4 may compete with TFEB for binding to CLEAR elements in the lysosomal gene promoters & inhibition of the CLEAR network genes |
APOE ɛ4/ɛ4 AD patients. |
|
[130] |
Increased TFEB expression |
AD patient fibroblasts carrying the familial presenilin-1 A246E mutation |
|
[131] |
TFEB levels are unchanged however, upregulation of a subset of CLEAR network genes |
presenilin-1 conditional KO mice |
|
[132] |
Transcriptome upregulation of TFEB targets |
5x-FAD mice |
|
[133] |
Enhanced levels of TFEB and TFE3 resulted in elevated expression of autophagy target genes |
Hippocampus of AD subjects |
|
[77] |
GSK inhibitor VIII induces TFEB nuclear translocation |
reduced APP levels in vitro |
|
[134] |
CNS delivery of TFEB selectively cleared p-Tau species |
rTg4510 mouse tauopathy model |
Rescue of behavioral phenotypes, synaptic deficits, & neurodegeneration |
[18] |
Neuron specific TFEB overexpression resulted in decline of toxic p-Tau & lipofuscin levels in the cortex and hippocampus |
P301S tauopathy mouse model |
Improved performance in memory & learning tests |
[81] |
Astrocyte-specific delivery of TFEB promoted Aβ uptake & clearance |
hippocampus of of APP/PS1 transgenic mice |
Reduced Aβ levels & hippocampal plaque load |
[19] |
SIRT1 causes the deacetylation of TFEB increased lysosomal biogenesis & microglial degradation of fibrillary Aβ |
ex vivo brain slices of APP/PS1 mice |
Reduction of amyloid plaque |
[135] |
GCN5 causes TFEB acetylation leading to inhibition of autophagy and lysosome biogenesis |
hTau Drosophila model |
hTau aggregates & neurotoxicity |
[136] |
Curcumin analog C1 activated TFEB, increased autophagy and lysosomal activity |
5xFAD, P301S and 3xTg-AD mice |
Improved synaptic & cognitive function |
[137] |